Literature DB >> 24660578

Reliability and validity of dermatology life quality index: assessment of quality of life in human immunodeficiency virus/acquired immunodeficiency syndrome patients with pruritic papular eruption.

Zhibin Liu, Zheng Xie, Li Zhang, Yantao Jin, Huijun Guo, Ziqiang Jiang, Xiumin Chen, Jun Yuan.   

Abstract

OBJECTIVE: To test the reliability and validity of dermatology life quality index (DLQI) in simplified Chinese language by assessing the quality of life (QoL) in HIV (human immunodeficiency virus)/AIDS (Acquired immunodeficiency syndrome) patients with pruritic papular eruption (PPE).
METHODS: A study of simplified-Chinese-version DLQI was carried out in Henan province, China. The reliability and validity were tested by means of statistical method. Data were processed with SPSS 19.0.
RESULTS: One hundred and seven subjects participated in the study and 106 (99.07%) finished the questionnaire. Eighteen patients were mildly affected; 62 were moderately affected, 24 were highly affected, and 2 were extremely affected. Reliability analysis showed that the split-half reliability coefficient of questionnaire was 0.556 and the reliability of the full test estimated with Spearman-Brown. correction was 0.7146. The Cronbach alpha was 0.673. According to validity analysis, the correlation between the scores of items and the total scores ranged from 0.208 to 0.529 (P < 0.05). Three factors were abstracted froml0 questions with the principal component analysis and the contribution rate of the 3 common factors was 59.95%.
CONCLUSION: The simplified-Chinese-version DIQL is an acceptable and valid scale for HIV/AIDS patients with PPE. It can be used to evaluate the QoL of HIV/AIDS patients with PPE in China.

Entities:  

Mesh:

Year:  2013        PMID: 24660578     DOI: 10.1016/s0254-6272(14)60024-8

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  1 in total

1.  Unified-planning, graded-administration, and centralized-controlling: a management modality for treating acquired immune deficiency syndrome with Chinese medicine in Henan Province of China.

Authors:  Li-Ran Xu; Hui-jun Guo; Zhi-bin Liu; Qiang Li; Ji-ping Yang; Ying He
Journal:  Chin J Integr Med       Date:  2015-04-16       Impact factor: 1.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.